Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences



Headline News

Giredestrant and everolimus significantly extend progression free survival in ER positive advanced breast cancer in phase III evERA results published in The New England Journal of Medicine


Bristol Myers Squibb adds $1 million community grant programme to second year of Champions in Care campaign


Sanofi and Regeneron bring four new long acting antibodies into Dupixent partnership in deal worth up to $8 billion


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Final Revised Version of BioPhorum Extractable Testing Recommendation Part 1

Presented by Frances Sexton, Carsten Worsøe, Ken Wong, and Satish Kumar
18th May 2020


Fully Utilizing Closed Systems in Modern BioPharma Facilities

Presented by Lars Hovmand-Lyster, Senior Engineering Specialist in Novo Nordisk Global Project Office (GPO) Engineering Management Department and Ross W. Acucena, Applications Director, Entegris LifeScience
03rd September 2020


Biopharmaceutical Process Model Evolution – Enabling Process Knowledge Continuum from an Advanced Process Control Perspective

Presented by Saly Romero-Torres, PhD, Senior Manager, Advanced Data Analytics, Biogen and David Lovett, Managing Director & John Mack, Engineering Director at Perceptive Engineering
15th November 2019


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia